125 related articles for article (PubMed ID: 31348785)
1. Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation.
Schmid AS; Neri D
PLoS One; 2019; 14(7):e0219313. PubMed ID: 31348785
[TBL] [Abstract][Full Text] [Related]
2. Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity.
Tosic V; Thomas DL; Kranz DM; Liu J; McFadden G; Shisler JL; MacNeill AL; Roy EJ
PLoS One; 2014; 9(10):e109801. PubMed ID: 25329832
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and expression analysis of interleukin 15 (IL15) and interleukin-15 receptor subunit alpha (IL15Rα) in dojo loach (Misgurnus anguillicaudatus): Their salient roles during bacterial, parasitic and fungal infection.
Chen X; Kong W; Yu Y; Dong S; Huang Z; Yu W; Xu J; Luo Y; Wang Q; Xu Z
Mol Immunol; 2018 Nov; 103():293-305. PubMed ID: 30343118
[TBL] [Abstract][Full Text] [Related]
4. An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.
Ma R; Lu T; Li Z; Teng KY; Mansour AG; Yu M; Tian L; Xu B; Ma S; Zhang J; Barr T; Peng Y; Caligiuri MA; Yu J
Cancer Res; 2021 Jul; 81(13):3635-3648. PubMed ID: 34006525
[TBL] [Abstract][Full Text] [Related]
5. A Novel Antibody-IL15 Fusion Protein Selectively Localizes to Tumors, Synergizes with TNF-based Immunocytokine, and Inhibits Metastasis.
Corbellari R; Stringhini M; Mock J; Ongaro T; Villa A; Neri D; De Luca R
Mol Cancer Ther; 2021 May; 20(5):859-871. PubMed ID: 33632875
[TBL] [Abstract][Full Text] [Related]
6. A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy.
Xu H; Buhtoiarov IN; Guo H; Cheung NV
Oncoimmunology; 2021 Mar; 10(1):1893500. PubMed ID: 33763293
[TBL] [Abstract][Full Text] [Related]
7. Differential Effects of IL2Rα and IL15Rα over the Stability of the Common Beta-Gamma Signaling Subunits of the IL2 and IL15 Receptors.
Ponce LF; Montalvo G; Leon K; Valiente PA
J Chem Inf Model; 2021 Apr; 61(4):1913-1920. PubMed ID: 33765385
[TBL] [Abstract][Full Text] [Related]
8. Essential role of interleukin-15 receptor in normal anxiety behavior.
Wu X; He Y; Hsuchou H; Kastin AJ; Rood JC; Pan W
Brain Behav Immun; 2010 Nov; 24(8):1340-6. PubMed ID: 20600810
[TBL] [Abstract][Full Text] [Related]
9. Cessation of blood-to-brain influx of interleukin-15 during development of EAE.
Hsuchou H; Pan W; Wu X; Kastin AJ
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1568-78. PubMed ID: 19536071
[TBL] [Abstract][Full Text] [Related]
10. Novel antibody-cytokine fusion proteins featuring granulocyte-colony stimulating factor, interleukin-3 and interleukin-4 as payloads.
Schmid AS; Tintor D; Neri D
J Biotechnol; 2018 Apr; 271():29-36. PubMed ID: 29438784
[TBL] [Abstract][Full Text] [Related]
11. Brain interleukin-15 in neuroinflammation and behavior.
Pan W; Wu X; He Y; Hsuchou H; Huang EY; Mishra PK; Kastin AJ
Neurosci Biobehav Rev; 2013 Feb; 37(2):184-92. PubMed ID: 23201098
[TBL] [Abstract][Full Text] [Related]
12. A novel strategy to produce high level and high purity of bioactive IL15 fusion proteins from mammalian cells.
Huang H; Luo Y; Baradei H; Liu S; Haenssen KK; Sanglikar S; Kumar S; Cini J
Protein Expr Purif; 2018 Aug; 148():30-39. PubMed ID: 29596991
[TBL] [Abstract][Full Text] [Related]
13. IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer Immunotherapy.
Beha N; Harder M; Ring S; Kontermann RE; Müller D
Mol Cancer Ther; 2019 Jul; 18(7):1278-1288. PubMed ID: 31040163
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeting properties of novel immunocytokines based on murine IL1β and IL6.
Hess C; Neri D
Protein Eng Des Sel; 2014 Jun; 27(6):207-13. PubMed ID: 24795343
[TBL] [Abstract][Full Text] [Related]
15. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
Pasche N; Wulhfard S; Pretto F; Carugati E; Neri D
Clin Cancer Res; 2012 Aug; 18(15):4092-103. PubMed ID: 22693354
[TBL] [Abstract][Full Text] [Related]
16. High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner.
Polansky JK; Bahri R; Divivier M; Duitman EH; Vock C; Goyeneche-Patino DA; Orinska Z; Bulfone-Paus S
Sci Rep; 2016 Jan; 6():19699. PubMed ID: 26822794
[TBL] [Abstract][Full Text] [Related]
17. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis].
Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773
[TBL] [Abstract][Full Text] [Related]
18. IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization.
Han KP; Zhu X; Liu B; Jeng E; Kong L; Yovandich JL; Vyas VV; Marcus WD; Chavaillaz PA; Romero CA; Rhode PR; Wong HC
Cytokine; 2011 Dec; 56(3):804-10. PubMed ID: 22019703
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.
Ng S; Deng J; Chinnadurai R; Yuan S; Pennati A; Galipeau J
Cancer Res; 2016 Oct; 76(19):5683-5695. PubMed ID: 27488533
[TBL] [Abstract][Full Text] [Related]
20. Contributions of interfacial residues of human Interleukin15 to the specificity and affinity for its private alpha-receptor.
Sakamoto S; Caaveiro JM; Sano E; Tanaka Y; Kudou M; Tsumoto K
J Mol Biol; 2009 Jun; 389(5):880-94. PubMed ID: 19406127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
